ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Obey Attacks NCI In Campaign Speech

October 29, 1976

In Brief: NCI Grants Up Fourfold Since 1970; Rappaport, Jensen Speakers At Annual AACR,ASCO Meeting

April 25, 1975

European Commission Approves Subcutaneous Rituximab

March 28, 2014

Simons Named CEO of Prostate Cancer Foundation.

November 17, 2006

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994